Figure 5. Establishment of the nomogram model. (A) A nomogram model was established based on four candidate disulfidptosis modulators. (B) The ROC result of our proposed signature in validation dataset GSE35956. (C) A calibration curve was utilised to evaluate the predictive accuracy of the nomogram model. (D) Decisions based on this nomogram model may be beneficial for clinical management of patients with OP. (E) A clinical impact curve was used to assess the clinical impact of the nomogram model.